CDIO Cardio Diagnostics Holdings Inc. - Common stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$1.92
Price · Aug 19, 2026
Fundamentals as of May 15, 2026
52W Range
$1–$8
14% of range
Analyst Rating
BUY
7 analysts
Price Target
—
P/E (TTM)
—
ROE
—
Net Profit Margin
—

CDIO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$1.92
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$1 – $8

CDIO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS —
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
CDIO
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
CDIO
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
CDIO
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
CDIO
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
CDIO
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
CDIO
Peer Median

CDIO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 7 analysts
  • Strong Buy 2 28.6%
  • Buy 4 57.1%
  • Hold 1 14.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
1.3%
Period EPS Actual EPS Est Surprise
March 31, 2025 $-0.97 $-1.84 0.87%
Dec. 31, 2024 $-0.30 $-1.84 1.5%
Sept. 30, 2024 $-1.80 $-3.06 1.3%
June 30, 2024 $-1.80 $-3.37 1.6%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
CDIO — — — — — —
FBLG — -0.5 — — — —
ERNA — — — — — —
ENSC $4M -0.2 -2.8% -200.9% -294.0% —
BOLT $11M -0.3 0.07% -433.7% -102.2% —
ACXP $6M -0.5 — — -180.3% —
PMCB $8M -0.3 — — -56.7% —
BRTX $10M -0.7 -10.3% -3959.4% -547.6% 93.4%
XBIO — -1.4 19.0% — — —
DRMA — — — — — —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 18 filers · $411K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
6 (+2 vs prior Q) 3 (-1 vs prior Q) 1 (-1 vs prior Q) 4 (0 vs prior Q) -46K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
RENAISSANCE TECHNOLOGIES LLC $107,748 49,200 26.19% Shares
BlackRock, Inc. $76,011 34,708 18.48% Shares
GEODE CAPITAL MANAGEMENT, LLC $45,595 20,820 11.08% Shares
VANGUARD CAPITAL MANAGEMENT LLC $44,139 20,155 10.73% Shares
CITADEL ADVISORS LLC $41,765 19,071 10.15% Shares
XTX Topco Ltd $35,244 16,093 8.57% Shares
STATE STREET CORP $22,117 10,099 5.38% Shares
JANE STREET GROUP, LLC $17,001 7,763 4.13% Shares
VANGUARD GROUP INC $10,756 3,969 2.61% Shares
VANGUARD FIDUCIARY TRUST CO $6,185 2,824 1.50% Shares
Tower Research Capital LLC (TRC) $3,962 1,809 0.96% Shares
UBS Group AG $335 153 0.08% Shares
WOLVERINE ASSET MANAGEMENT LLC $228 104 0.06% Shares
MORGAN STANLEY $219 100 0.05% Shares
OSAIC HOLDINGS, INC. $35 16 0.01% Shares
SHP Wealth Management $35 16 0.01% Shares
SBI Securities Co., Ltd. $22 10 0.01% Shares
WELLS FARGO & COMPANY/MN $4 2 0.00% Shares

Company insiders 1 insider · 0 officers · 0 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Mana Capital LLC 10% owner Oct. 25, 2022 J 0 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 3 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Robert Philibert, BD Holding, Inc. ×2 filings June 28, 2023 — Initial filing — SEC
Meeshanthini Dogan, Timur Dogan ×2 filings June 28, 2023 — Initial filing — SEC
Mana Capital LLC Dec. 3, 2021 — Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 1 ETF

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS 0.00% 20,155 SH Aug. 8, 2026 Daily